Derek C Angus,Alison J Huang,Roger J Lewis,Amy P Abernethy,Robert M Califf,Martin Landray,Nancy Kass,Kirsten Bibbins-Domingo,JAMA Summit on Clinical Trials Participants,Ali B Abbasi,Kaleab Z Abebe,Stacey J Adam,Jamy Ard,Rachel A Bender Ignacio,Scott M Berry,Deepak L Bhatt,Robert O Bonow,Marc Bonten,Sharon A Brangman,John Brownstein,Melinda J B Buntin,Atul J Butte,Marion K Campbell,Anne R Cappola,Anne C Chiang,Deborah Cook,Steven R Cummings,Gregory Curfman,Laura J Esserman,Lee A Fleisher,Joseph B Franklin,Ralph Gonzalez,Cynthia I Grossman,Tufia C Haddad,Roy S Herbst,Adrian F Hernandez,Diane P Holder,Leora Horn,Grant D Huang,Alison Huang,Rohan Khera,Walter J Koroshetz,Harlan M Krumholz,Tracy A Lieu,Preeti N Malani,Christa Lese Martin,Mark McClellan,Mary M McDermott,Stephanie R Morain,Susan A Murphy,Stuart G Nicholls,Stephen J Nicholls,Peter J O'Dwyer,Bhakti K Patel,Eric Peterson,Sheila A Prindiville,Joseph S Ross,Kathryn M Rowan,Gordon Rubenfeld,Christopher W Seymour,Rod S Taylor,Joanne Waldstreicher,Tracy Y Wang

Abstract:Importance: Optimal health care delivery, both now and in the future, requires a continuous loop of knowledge generation, dissemination, and uptake on how best to provide care, not just determining what interventions work but also how best to ensure they are provided to those who need them. The randomized clinical trial (RCT) is the most rigorous instrument to determine what works in health care. However, major issues with both the clinical trials enterprise and the lack of integration of clinical trials with health care delivery compromise medicine's ability to best serve society. Observations: In most resource-rich countries, the clinical trials and health care delivery enterprises function as separate entities, with siloed goals, infrastructure, and incentives. Consequently, RCTs are often poorly relevant and responsive to the needs of patients and those responsible for care delivery. At the same time, health care delivery systems are often disengaged from clinical trials and fail to rapidly incorporate knowledge generated from RCTs into practice. Though longstanding, these issues are more pressing given the lessons learned from the COVID-19 pandemic, heightened awareness of the disproportionate impact of poor access to optimal care on vulnerable populations, and the unprecedented opportunity for improvement offered by the digital revolution in health care. Four major areas must be improved. First, especially in the US, greater clarity is required to ensure appropriate regulation and oversight of implementation science, quality improvement, embedded clinical trials, and learning health systems. Second, greater adoption is required of study designs that improve statistical and logistical efficiency and lower the burden on participants and clinicians, allowing trials to be smarter, safer, and faster. Third, RCTs could be considerably more responsive and efficient if they were better integrated with electronic health records. However, this advance first requires greater adoption of standards and processes designed to ensure health data are adequately reliable and accurate and capable of being transferred responsibly and efficiently across platforms and organizations. Fourth, tackling the problems described above requires alignment of stakeholders in the clinical trials and health care delivery enterprises through financial and nonfinancial incentives, which could be enabled by new legislation. Solutions exist for each of these problems, and there are examples of success for each, but there is a failure to implement at adequate scale. Conclusions and relevance: The gulf between current care and that which could be delivered has arguably never been wider. A key contributor is that the 2 limbs of knowledge generation and implementation-the clinical trials and health care delivery enterprises-operate as a house divided. Better integration of these 2 worlds is key to accelerated improvement in health care delivery.

Making causal inferences from transactional data: A narrative review of opportunities and challenges when implementing the target trial framework

Causal Inference and Counterfactual Prediction in Machine Learning for Actionable Healthcare

Target Trial Emulation: A Call for More Widespread Use

Leveraging text data for causal inference using electronic health records

Learning Causal Effects From Observational Data in Healthcare: A Review and Summary

TRIALSCOPE: A Unifying Causal Framework for Scaling Real-World Evidence Generation with Biomedical Language Models

Causal thinking for decision making on Electronic Health Records: why and how

Causal inference methods for combining randomized trials and observational studies: a review

Applying the estimand and target trial frameworks to external control analyses using observational data: a case study in the solid tumor setting

Reference-trial-informed design to explore treatment effects in trial-underrepresented subgroups

Clinical trial emulation in nephrology

Causal Inference in Observational Data

An Application of the Causal Roadmap in Two Safety Monitoring Case Studies: Covariate-Adjustment and Outcome Prediction using Electronic Health Record Data

Towards causally interpretable meta-analysis: transporting inferences from multiple studies to a target population

Big Data, Data Science, and Causal Inference: A Primer for Clinicians

The Causal Roadmap and Simulations to Improve the Rigor and Reproducibility of Real-data Applications

The Integration of Clinical Trials With the Practice of Medicine: Repairing a House Divided

Linking clinical trial participants to their U.S. real-world data through tokenization: A practical guide

The Causal Plausibility Decision in Healthcare

A Causal Framework for Making Individualized Treatment Decisions in Oncology

Leveraging big data for causal understanding in mental health: a research framework